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The Fanconi anemia (FA) core complex provides the
essential E3 ligase function for spatially defined
FANCD2 ubiquitination and FA pathway activation.
Of the seven FA gene products forming the core
complex, FANCL possesses a RING domain with
demonstrated E3 ligase activity. The other six com-
ponents do not have clearly defined roles. Through
epistasis analyses, we identify three functional mod-
ules in the FA core complex: a catalytic module con-
sisting of FANCL, FANCB, and FAAP100 is absolutely
required for the E3 ligase function, and the FANCA-
FANCG-FAAP20 and the FANCC-FANCE-FANCF
modules provide nonredundant and ancillary func-
tions that help the catalytic module bind chromatin
or sites of DNA damage. Disruption of the catalytic
module causes complete loss of the core complex
function, whereas loss of any ancillary module
component does not. Our work reveals the roles of
several FA gene products with previously undefined
functions and a modularized assembly of the FA
core complex.
INTRODUCTION
Fanconi anemia (FA) is a complex genetic disorder encompass-
ing 16 tumor suppressor genes that act together to protect cells
against genotoxic stress, particularly complexed DNA lesions
such as DNA interstrand crosslinks (Bogliolo et al., 2013; D’An-
drea, 2010) and potentially DNA-protein crosslinks created by
endogenous metabolites (Langevin et al., 2011; Rosado et al.,
2011). Classical manifestations of FA include pancytopenia,
chromosomal abnormalities, congenital abnormalities, and a
high predisposition to a broad spectrum of cancers. Despite
the identification of genetic defects in patients with FA, theCmolecular mechanism underpinning FA pathway functions re-
mains unclear.
A group of classical FA genes is connected by a DNA damage-
induced monoubiquitination reaction in the nucleus (Garcia-Hi-
guera et al., 2001; Smogorzewska et al., 2007; Taniguchi et al.,
2002). Monoubiquitination of the FANCD2/I complex has the
presumed functions of recruiting DNA lesion-processing endo-
nucleolytic activities (Knipscheer et al., 2009; Kratz et al., 2010;
Liu et al., 2010; MacKay et al., 2010; Smogorzewska et al.,
2010) and transcriptional activation of tumor suppressor genes
(Park et al., 2013). The E3 ligase activity of this reaction resides
in the FA core complex consisting of seven FA proteins (FANCA,
FANCB, FANCC, FANCE, FANCF, FANCG, and FANCL) and
two FA-associated proteins (FAAP20 and FAAP100), with the
RING domain protein FANCL bearing the E3 ligase activity (Alpi
et al., 2008; Meetei et al., 2003). Aside from FANCL and
FAAP20, most other components of the core complex have
neither recognizable motifs nor clearly defined functions as to
how they contribute to the DNA damage-mediated FANCD2/I
monoubiquitination.
Studies of protein-protein interactions within the FA core
complex have suggested the existence of three subcomplexes
(Figure 1A). FANCA, FANCG, and FAAP20, form a subcomplex
(A-G-20) (Ali et al., 2012; Garcia-Higuera et al., 1999; Kruyt
et al., 1999; Reuter et al., 2000; Waisfisz et al., 1999). The UBZ
domain of FAAP20 is suggested to bind to ubiquitinated histone
(Leung et al., 2012; Yan et al., 2012). FANCG contains seven TPR
repeats and is considered a possible scaffold for the subcomplex
(Blom et al., 2004; Le´veille´ et al., 2004). The FANCB-FANCL-
FAAP100 subcomplex (B-L-100) contains the E3 ligase FANCL
(Ling et al., 2007; Medhurst et al., 2006). Given that FANCL alone
acts sufficiently in reconstituted ubiquitination reactions (Alpi
et al., 2008; Longerich et al., 2009; Sato et al., 2012), whether
FANCB and FAAP100 contribute to the E3 activity is unclear. A
third subcomplex is formed by FANCC, FANCE, and FANCF
(C-E-F). FANCF has been shown to interact with FANCM (Deans
and West, 2009) and was also suggested to act as an adaptor
protein (Le´veille´ et al., 2004). Despite these observations, theell Reports 7, 1849–1857, June 26, 2014 ª2014 The Authors 1849
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Figure 1. Various Sensitivities of FA Knockout Mutants Identify the FA Core Complex Catalytic Module
(A) Depiction of three protein interaction modules within the FA core complex and the FANCM-FAAP24 complex. See also Figures S1A–S1C.
(B) Clonogenic survival of wild-type HCT116 (WT), FANCB, FANCG/, and FANCBG/ mutants treated with mitomycin C. See also Figures S1D, S1E,
and S2.
(C) Clonogenic survival of wild-type HCT116 (WT), FANCB, FAAP20/, and FANCBFAAP20/ mutants treated with mitomycin C. See also Figure S2.
(D) Clonogenic survival of wild-type HCT116 (WT), FAAP20/, FANCG/, FANCB, and FANCL/ mutants treated with mitomycin C.
(E) Immunoblots detecting MMC- or cisplatin-induced monoubiquitination of chromatin-bound FANCD2 and FANCI in wild-type HCT116 cells (WT) and the
indicated knockout mutants. See also Figures S3A and S3B.
(F) Immunoblot detecting MMC- or cisplatin-induced monoubiquitination of chromatin-bound FANCD2 in wild-type chicken DT40 (WT) and indicated knockout
mutants. *FANCG gene localizes in the single Z chromosome and only one allele exists in DT40 cells. See also Figures S3C and S3D.
(G) Immunoblots detecting FANCL auto ubiquitination in protein extracts prepared from 293T cells stably expressing SPB-FAAP100 and/or SFB-FANCL with or
without MMC treatment. Protein extracts from indicated cell lines were subjected to S beads pull-down and immunoblotted by antiubiquitin or Flag antibodies.
(H) Superose 6 gel filtration profiling of the FA core complex in HCT116WT, FANCG/, and FANCL/mutants. Nuclear extracts were fractionated by Superose
6 gel filtration, and the indicated fractions were immunoblotted (IB) with FANCL or FAAP100 antibodies. The arrow indicates the elution position of the FA core
complex (670 kDa). Fraction 21 marks the void.
Error bars in survival curves were derived from SDs from four to six independent experiments with triplicates.function of each subcomplex and how they integrate together in
the context of the FA core complex remain largely unclear.
Because that conservation of the classical FA pathway is pri-
marily within vertebrates, typical genetic platforms such as yeast
or Drosophila could not be employed to reveal the interaction
among FA genes. In this study, we undertook an epistatic anal-
ysis approach with mammalian and chicken DT40 cells to eluci-
date the functions of the FA core components. By generating a
series of isogenic loss-of-function single and double mutants of
key core complex genes, we find that loss of different FA core
components gave rise to variable impacts on the activation of
the FApathway andcorrespondingly variable cellular sensitivities
to crosslinking reagents. Here, we present evidence that the dif-
ferential sensitivities reflect distinct functions of the FA core com-
plex components, suggesting amodularized functional assembly
of the core complex that enables it to carry out the spatially
defined monoubiquitination reaction upon DNA damage.1850 Cell Reports 7, 1849–1857, June 26, 2014 ª2014 The AuthorsRESULTS
Differential Damage Sensitivities of FACoreComponent
Mutants
FA core complex components form three protein interaction
modules: A-G-20, B-L-100, and C-E-F, as suggested by several
groups and us (Le´veille´ et al., 2004; Ling et al., 2007; Medhurst
et al., 2006; Yan et al., 2012) (Figures 1A and S1A–S1C). To
address the functionality of each protein interaction module in
cellular survival against DNA damage, we created FANCG/,
FANCB, and a FANCG/FANCB double-knockout mutants
via homologous replacement targeting (Figures S2A, S2B, and
S2D) in the HCT116 parental cell background. The strict isoge-
nicity among these knockout mutants allows direct comparison
of cellular survival outcomes as a direct reflection of protein
function. Using clonogenic survival assay, we found that
the FANCG/ mutant was significantly more resistant than
FANCB to crosslinking DNA damage (Figures 1B, S1D, and
S1E), but deletion of both genes did not produce any additional
sensitivity over that of FANCB. These differential sensitivities
suggest that FANCB has an epistatic yet more important role
than FANCG in cellular resistance to crosslinking DNA damage.
Because FANCG and FAAP20 reside in the same module, we
next tested FAAP20/ and FAAP20/FANCB knockout mu-
tants (Figures 1C and S2E) and observed a similar survival pro-
file, which implicates an epistatic but more essential function
of FANCB in cellular resistance to crosslinking reagents.
Loss of FANCB led to marked decrease of FANCL protein
levels (Figure S1A). Thus, it is plausible that the strong damage
sensitivity of the FANCB mutant is attributable to its presence
in the same protein-association module with FANCL and to its
ability to stabilize FANCL. To test this premise, we compared
four isogenic HCT116 knockout mutants (Figure 1D) for their
crosslinking damage sensitivity and found that loss of FANCL
or FANCB rendered comparable but much more severe pheno-
types than loss of FANCG or FAAP20. The different degrees of
sensitivities from distinct components of the FA core complex
seem to indicate distinct functions executed by the two different
protein modules.
FANCD2 monoubiquitination is a critical determinant of cell
survival against crosslinking agents. We reasoned that the differ-
ential sensitivities of the different FA core component mutants
might reflect their ability to influence the level of FANCD2 mono-
ubiquitination. To verify this notion, we examined a panel of
HCT116 (human) and DT40 (chicken) somatic cellular knockout
mutants for DNA-damage-induced FANCD2monoubiquitination,
using chromatin fractions prepared from cells exposed to mito-
mycin C or cisplatin. We found that mutants devoid of FANCL,
B, or FAAP100 exhibited complete loss of FANCD2 and FANCI
monoubiquitination, whereas loss of FANCA, G, E, or FAAP20
showed readily detectable levels of FANCD2 and FANCI monou-
biquitination (Figures 1E and 1F). To ascertain that the absence
or reduction of FANCD2 monoubiquitination was not a result of
differential FANCD2 protein loss in the knockout mutants, chro-
matin-bound and soluble protein fractions were tested for their
FANCD2 levels. We found (Figure S3) that each knockout mutant
maintained an amount of total FANCD2 comparable to that in the
parental HCT116 or DT40 cells.
To explore the potential function of FAAP100 in the FA path-
way activation, we coexpressed SFB-tagged FANCL and/or
FAAP100 in 293T cells and analyzed FANCL auto ubiquitination
in the presence of absence ofmitomycin C (Figure 1G).We found
that overexpression of FAAP100 increased strongly FANCL
autoubiquitination, suggesting that FAAP100may have functions
in helping FANCL engaging its targets in a cellular context. These
results collectively suggest that FANCL, B, and FAAP100 consti-
tute a catalytic core that is absolutely essential for the E3 ligase
activity of the FA core complex. These three proteins most likely
form a highly integrated module as demonstrated by a strong
interdependency of protein stabilities where loss of FANCB
is accompanied by drastic decreases of both FANCL and
FAAP100 (Figure S1C) (Ling et al., 2007; Medhurst et al., 2006).
On the other hand, the A-G-20 and C-E-F modules seem to
have auxiliary roles in FA core complex function. However, com-
plete loss of the E3 ligase activity of the core complex may alsoCarise from disruption of the entire core complex. To examine
this possibility, we performed gel filtration profiling of FA core
component knockout mutants and found that deletion of FANCG
and FANCL did not result in a gross disruption of the core com-
plex (Figure 1H), which is reflected by the similar elution positions
of themutant core complex to that of the wild-type FA core com-
plex (670 kDa) (Figure 1H).
Chromatin and DNA Damage Association of the Core
Complex Depend on Both the A-G-20 and the C-E-F
Modules
E3 ligases are either monomeric, such as HECT domain-contain-
ing E3 ligases, or multisubunit such as cullin-based E3s with
adaptor and substrate-recognition components in addition to the
catalytic subunit (Metzger et al., 2012; Zimmerman et al., 2010).
Even though the FA core complex contains nine subunits, FANCL
was found tobe singly competent inmonoubiquitinating FANCD2/
I in vitro together with Ube2t (Alpi et al., 2008; Hodson et al., 2014;
Longerich et al., 2009; Sato et al., 2012), suggesting that the A-G-
20 and C-E-F modules may have functions autonomous to the E3
catalyticcoremodule.Because theFAcorecomplex is recruited to
chromatin upon DNA damage, monoubiquitination of FANCD2/I
most likely takes place in a spatially defined fashion, which entails
the core complex to be localized to the site of DNA lesions.
To search for such modular activities, we measured damage-
induced chromatin loading of FANCL in FANCB, FANCG/,
and FANCL/ mutants (Figures 2A and 2B). As expected,
much reducedFANCLchromatinpresencewas found inFANCB
mutant because of its reduced FANCL protein level. However,
despite normal FANCL protein abundance, FANCL chromatin
binding in FANCG/ was drastically reduced to approximately
10% that of the wild-type cells. This result suggests that chro-
matin retention of the E3 ligase activity relies on the presence of
FANCG. Deletion of FAAP20 led to partial loss of FANCL chro-
matin binding, indicating a minor role of FAAP20 in FANCL chro-
matin association. Conversely, FANCG chromatin binding, albeit
weakened compared to wild-type cells, maintained a significant
level in FANCB and FANCL/ mutant cells (Figures 2A and
2C). Thus, the A-G-20 module seems to be able to associate
with chromatin in the absence of the FANCL-based catalytic
module, raising the possibility that the A-G-20 module supports
the localization of the catalytic core to the site of DNA lesions.
To validate this notion, we used the episomal chromatin
immunoprecipitation (eChIP) (Shen et al., 2009) assay with
psoralen- or cisplatin-damaged DNA substrates to assess the
DNA damage-dependent enrichment of FANCG and FANCL in
FANCL/ and FANCG/ mutants, respectively. Consistent
with the chromatin fractionation results, we found that damage-
dependent FANCG enrichment does not require FANCL (Figures
2D and 2E), whereas enrichment of FANCL strongly depends on
the presence of FANCG (Figures 2F and 2G). Altogether, these
observations support that the A-G-20 module likely acts as a
chromatin-binding component of the FA core complex.
Cell biology evidence suggests that FANCA nuclear localiza-
tion relies on its interaction with FANCL or FANCB for nuclear
localization (Medhurst et al., 2006). Thus, it is plausible that
FANCB/ and FANCL/mutant phenotypes and the composi-
tion of the FA core complex may also be complicated by aell Reports 7, 1849–1857, June 26, 2014 ª2014 The Authors 1851
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Figure 2. The A-G-20 Module Is Required for FANCL Association with DNA Damage
(A) Chromatin binding of FANCG and FANCL in wild-type HCT116 cells (WT) and the indicated mutants exposed to mitomycin. Histone H3 served as a loading
control for chromatin-bound protein fractions.
(B) Quantification of chromatin-bound FANCG in FANCB, G/, L/, and FAAP20/ knockout mutants.
(C) Quantification of chromatin-bound FANCL in FANCB, G/, L/, and FAAP20/ knockout mutants.
(D) eChIP analysis of FANCG enrichment to a defined psoralen lesion in wild-type HCT116 cells (WT)and the FANCL/ mutant.
(E) eChIP analysis of FANCG enrichment to a cisplatin-adducted plasmid substrate in wild-type HCT116 cells (WT) and the FANCL/ mutant.
(F) eChIP analysis of FANCL enrichment to a defined psoralen lesion in wild-type HCT116 cells (WT) and the FANCG/ mutant.
(G) eChIP analysis of FANCL enrichment to a cisplatin-adducted plasmid substrate in wild-type HCT116 cells (WT) and the FANCG/ mutant.
(H) Immunoblotting of FANCA in cytoplasmic (C), nuclear (N), and whole-cell protein extracts from FANCB,FANCL/, and FANCG/ mutant cells. Tubulin,
histone H3, and MCM4 are controls for loading and extraction.
Error bars for chromatin fraction and eChIP analyses represent SDs derived from three independent experiments.potential absence of FANCA from the nucleus. To determine how
FANCA localization is affected in the FANCB and FANCL/
mutants, we analyzed whole-cell, cytoplasmic, and nuclear ex-
tracts prepared from FANCG/, FANCB/, and FANCL/
cells. As shown in Figure 2H, significant nuclear presence of
FANCA is found in both FANCB/, and FANCL/ cells despite
moderately reverted cytoplasmic/nuclear ratios when compared
to WT cells. Loss of FANCG resulted in reduced FANCA in both
nuclear and cytoplasmic fractions. These observations suggest
that loss of FANCB or FANCL do not eliminate the A-G-20 mod-
ule, consistent with the positive detection of FANCA-FANCG
interaction in FANCB/ and FANCL/ cells (Figure S1B).
Upon DNA damage, the FA core complex is initially loaded
onto the chromatin by the FANCM/FAAP24 complex via interact-1852 Cell Reports 7, 1849–1857, June 26, 2014 ª2014 The Authorsingwith FANCF (Figure S4A) (Deans andWest, 2009;Wang et al.,
2013b), suggesting that the FANCF-containing module (C-E-F)
may serve as a separate chromatin-binding element within the
FA core complex. Moreover, the residual level of FANCL chro-
matin binding in the FANCG/ mutant (Figures 2A and 2B)
also indicates that, aside from FANCG, a separate factor acts
in the damage-induced chromatin enrichment of FANCL. To
test whether the C-E-F module contributes independently to
the full extent of FANCD2 ubiquitination, we depleted FANCF
in wild-type HCT116 cells (Figures S4B–S4F) and found that
loss of FANCF alone resulted in a moderate reduction of
FANCD2 monoubiquitination and chromatin-bound FANCL (Fig-
ures 3A and 3B), indicating a chromatin-association function for
FANCF. When FANCF was depleted in the FANCG/ mutant
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Figure 3. The A-G-20 and C-E-F Modules
Exhibit Nonredundant Functions in the
Chromatin Recruitment of the FA Core
Complex and Resistance to Crosslink
Damage
(A) Immunoblot detecting monoubiquitination of
FANCD2 and chromatin-bound FANCL in cells
exposed to mitomycin C (left panel) or cisplatin
(right panel) in wild-type HCT116 (WT) and the
indicated knockout/knockdown mutant cells. See
also Figure S4.
(B) Quantification of chromatin-bound FANCL (left
panel of A) in wild-type HCT116 (WT), FANCG/ +
Ctrl shRNA, WT + shFANCF alone (shFANCF),
FANCG/ + shFANCF, and FANCL/ cells
exposed to mitomycin C. See also Figure S4.
(C) Clonogenic survival of parental HCT116 (WT),
FANCG/ + Ctrl shRNA, FANCG/ + shFANCF,
and FANCL/ cells treated withmitomycin C. See
also Figure S4.
(D) Clonogenic survival of parental DT40 (WT),
FANCE/, FANCG, and FANCE/FANCG
cells treated with cisplatin. See also Figure S2C.
Error bars for chromatin-bound FANCL quantifi-
cation (B) and clonogenic survivals (C and D) were
derived from SDs from three or more independent
tests.background, FANCD2 monoubiquitination as well as FANCL
chromatin enrichment was completely abolished. However,
FANCF chromatin binding was not affected in FANCG/ cells
treated with mitomycin C (Figure S4G). Together, these results
suggest that the A-G-20 and C-E-F modules can act indepen-
dently to facilitate the chromatin binding of the catalytic module.
Consistently, cells devoid of both FANCG and FANCF
(FANCG/ + shFANCF) exhibited much profound sensitivity to
mitomycinCasopposed to lossof FANCGor FANCFalone, com-
parable to that of the FANCL/ mutant (Figure 3C). The much
heightened sensitivity of FANCG/ + shFANCF cells most likely
reflects a complete loss of FANCD2monoubiquitination resulting
from the complete absence of the catalytic module at the site of
DNA damage. Given that FANCE and FANCF reside in the
same module, we further validated the nonredundant functions
of the A-G-20 and C-E-F modules by generating a FANCE/
FANCG double-knockout mutant in DT40 cells and compared
its clonogenic survival against that of FANCE/ and FANCG
single mutants (Figures 3D and S2C). Loss of both FANCG and
FANCE led to drastically increased cellular sensitivity, implicating
independent functions of A-G-20 and C-E-F modules, possibly
through promoting the recruitment of the core complex to the
site of DNA damage.Cell Reports 7, 1849–185FANCM Functions Epistatically
with the C-E-F Module in FA Core
Complex Chromatin Association
The above results suggest that FANCF
acts as a chromatin-enrichment factor
for the FA core complex via its interaction
with FANCM. As such, depletion of both
FANCM and FANCF is expected to yieldno additional phenotype than loss of FANCM alone as loss of
one or both proteins lead to disrupted core complex loading.
To test this premise, we analyzed FANCD2 monoubiquitination
in FANCM/ cells stably depleted of FANCF. As shown in Fig-
ures 4A and 4B, loss of FANCF in FANCM/ cells produced no
additional loss of FANCD2 or FANCI monoubiquitination upon
DNA damage. Consistently, loss of both FANCM and FANCF
(FANCM/ + shFANCF) also failed to acquire additional cellular
sensitivity over that of the FANCM/ mutant alone (Figure 4C).
Therefore, FANCMand FANCF functions appear epistatic in sup-
porting the chromatin association of the core complex.
In contrast, the A-G-20 and C-E-F modules seem to possess
independent functions in supporting chromatin binding of the
catalytic module. To completely abolish DNA/chromatin binding
of the core complex and FA pathway-mediated cell survival, both
modules have to be disrupted. As shown in Figure 3, disruption
of the C-E-F and A-G-20 modules led to compromised FA
pathway activation and interstrand crosslink (ICL) resistance.
To further verify the nonredundant recruitment functions of the
A-G-10 and the C-E-F modules, we constructed a FANCG/
FANCM/ double mutant (Figure S2F). Although FANCG/
and FANCM/ both retained significant levels of chro-
matin-bound FANCL, the FANCG/FANCM/ double mutant7, June 26, 2014 ª2014 The Authors 1853
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Figure 4. FANCM Functions Epistatically with the C-E-F Module in FA Core Complex Chromatin Association
(A) Immunoblot detecting mitomycin C-induced monoubiquitination of FANCD2 and FANCI in wild-type HCT116 cells (WT) and the indicated knockout/
knockdown mutant cells. See also Figure S4.
(B) Immunoblot detecting cisplatin-inducedmonoubiquitination of FANCD2 in wild-type HCT116 cells (WT) and the indicated knockout/knockdownmutant cells.
See also Figure S4.
(C) Clonogenic survival of HCT116 FANCF knockdown alone (shFANCF), FANCM/ + shFANCF, and FANCM/ + Ctrl shRNAmutants treated with mitomycin
C. See also Figure S4.
(D) Immunoblot detecting MMC-induced monoubiquitination of FANCD2 and chromatin binding of FANCL in wild-type HCT116 cells (WT) and the indicated
mutant cells exposed to mitomycin C. Histone H3 serves as a loading control for chromatin-bound protein fractions. See also Figure S2F.
(E) Quantification of (C) chromatin-bound FANCL in FANCG/, FANCM/, and FANCG/M/ double mutants. See also Figure S2F.
(F) Clonogenic survival of wild-type HCT116 cells (WT), FANCM/, FANCG/, FANCL/, and FANCG/M/ mutants treated with mitomycin C. See also
Figure S2F.
Error bars for chromatin fraction represent SDs derived from three independent experiments. Error bars for clonogenic survival are derived from SDs from four
independent tests done in triplications.completely lost chromatin-bound FANCL (Figures 4D and 4E).
Congruent with this observation, only the ablation of both
FANCG and FANCM yielded complete loss of FANCD2 monou-
biquitination (Figure 4D), further suggesting that the A-G-20
module and the FANCM-dependent C-E-F module provide
a combined recruitment for the FA core complex to execute
the spatially defined FANCD2/I monoubiquitination reaction.
Consistently, the DNA damage sensitivity of the FANCG/
FANCM/ double mutant was much more pronounced than
that of each single mutant (Figure 4F), demonstrating the func-
tional impact of eliminating both recruiting elements of the FA
core complex. The additional sensitivity of the FANCG/
FANCM/ mutant over that of the FANCL/ mutant is most
likely attributable to FANCM functions independent of the FA
mechanism (Huang et al., 2010; Wang et al., 2013b).
DISCUSSION
Through creation of isogenic single and doublemutants of the FA
genes, we came to the unexpected finding that not all the com-1854 Cell Reports 7, 1849–1857, June 26, 2014 ª2014 The Authorsponents of the core complex contribute equally to cellular resis-
tance against DNA damage. This observation deviates from a
general paradigm that losing any one of the core FA proteins
leads to complete elimination of FANCD2 activation and disinte-
gration of the core complex. Instead, our results suggest that
different functional modules exist in the core and that the overall
integrity of the core complex is sustained when certain FA pro-
teins are removed.
Our work establishes amodularized functional assembly of the
FA core complex consisting of a catalytic module and two mod-
ules with nonredundant functions in the chromatin recruitment of
the core complex. The coordinated actions of these three mod-
ules enable the E3 ligase activity to be localized to the sites of
DNA damage and carry out the spatially defined FANCD2/I
monoubiquitination with maximum efficiency to counter DNA
damage. The catalytic core module is the most critical compo-
nent functionally, as reflected by the most severe phenotypes
of the FANCL and FANCBmutants. The existence of a catalytical
core module within the FA core complex is further supported by
biochemical evidence from Rajendra et al. (2014). The reason
why the FANCL E3 ligase needs to form a catalytic core with
FANCB and FAAP100 is unclear. A plausible scenario could be
that FANCB and FAAP100 play a role in substrate engagement
or stimulating the E3 ligase activity of FANCL as reflected by
the fact that overproduction of FAAP100 leads to much elevated
levels of FANCL activity (Figure 1G). Gel filtration profiling of FA
core component knockout mutants showed that deletion of
FANCG and FANCL did not result in a gross disruption of the
core complex (Figure 1H). However, it is possible that certain
core components are critical for retaining the overall integrity
of the complex (Gordon et al., 2005). Additional studies may be
required to verify whether such structural components for the
core complex exist.
We have demonstrated that FANCF and FANCM have
epistatic roles in recruiting the core complex to the site of DNA
damage. The upstream role of FANCM in chromatin binding of
the FA core complex suggests that the C-E-F sub complex
may serve as an initial loading module for the core complex.
When the A-G-20 or the C-E-F module is individually defective,
the monoubiquitination is weakened but not fully diminished.
Disruption of both, however, eliminates the chromatin binding
and DNA damage localization of the core complex. As a result,
the FANCL E3 ligase activity is no longer in the vicinity of DNA-
bound FANCD2/I, which is a much more robust substrate than
the unbound form.
Our model of nonredundant recruitment functions of the
A-G-20 and the C-E-F modules may also explain the enhanced
phenotypes of the FANCC-FANCG double-knockout mice
(Pulliam-Leath et al., 2010). How the A-G-20 module promotes
the chromatin E3 ligase activity remains unclear. FANCA has
been shown to exhibit DNA binding affinity in vitro (Yuan
et al., 2012). FAAP20 can bind to ubiquitinated forms of H2A
(Yan et al., 2012), although the weak phenotypes of FAAP20
mutant suggest a secondary role for FAAP20 in chromatin as-
sociation of the core complex. These biochemical properties
could afford the A-G-20 module the ability to bind to DNA/
chromatin.
FANCM is known to be important for the chromatin associa-
tion of the core complex. Although deletion of FANCM results
in substantial loss of steady-state levels of FANC core complex
binding to chromatin, the decrease in FANCD2 monoubiquitina-
tion is moderate (Wang et al., 2013a, 2013b). It is likely that the
A-G-20 module, in the absence of the FANCM-mediated recruit-
ment, is sufficient to support a transient presence of the E3 ligase
activity at the site of DNA damage. This notion is substantiated
by the complete elimination of FANCD2 monoubiquitination in
the FANCG/M/ double mutant and in the FANCG/FANCF
knockdown cells.
The modular model of the FA core complex offers insights into
several FA genes that had no previously defined functions. How-
ever, further validation of this model requires biochemical and
structural investigations. The varying importance of different
core components may also contribute to the skewed prevalence
of gene mutations in FA patients. Mutations in FANCA, C, and G
together account for nearly 90% of all patient mutations,
whereas FANCB and FANCL patients account for less than 1%
(Neveling et al., 2009). This biased distribution may reflect
the functional importance of each gene in the FA pathway. OurCresults refine and advance the molecular understanding of
this important DNA damage response and tumor suppressor
pathway by revealing the functional divergence among the FA
core complex components.
EXPERIMENTAL PROCEDURES
Cell Culture and Antibodies
HCT116 cells, somatic knockout mutants, and HEK293T cells were all cultured
in DMEM plus 10% fetal bovine serum (FBS) at 37C. DT40 wild-type and
knockout cells were generated via published procedures and cultured in
RPMI-1640 medium plus 10% FBS, 1% chicken serum, 5 mM 2-mercaptoe-
thanol, and 10 mM HEPES, at 39.5C.
Antibodies against FANCL, FAAP100 (affinity purified), FAAP20, FANCM,
and anti-chicken FANCD2 were a kind gift from Weidong Wang’s laboratory
(National Institute on Aging). Commercial antibodies used are as follows:
anti-human FANCD2 (Abcam ab2187, Santa Cruz Biotechnology SC-20022,
Novus Biologicals NB100-182); anti-human FANCI (Bethyl Laboratories
A300-254A); anti-human FANCA (Bethyl A301-980A); anti-human FANCG
(Novus NB100-2566); anti-histone H3 (Millipore 05-928); anti-b-tubulin
(Sigma-Aldrich T4026); anti-FLAG M2 (Sigma-Aldrich F3165).
Construction of Somatic Cellular Knockout Mutants
Targeting vectors for human HCT116 cells were constructed using the USER
system as described previously (Wang et al., 2013b). Each mutant was vali-
dated by complementation with a wild-type cDNA of the targeted gene.
FANCE DT40 mutant was constructed by replacing a 5.3 kb coding area
(encompassing ten exons) with Bsr resistance gene cassette. Positive clones
were identified by Southern blotting with HindIII-digested genomic DNA. Tar-
geting of FANCG in DT40 cells was done as previously described (Yamamoto
et al., 2003). The FANCE/G double mutant was constructed sequentially by
targeting FANCG in a FANCE/ mutant.
Clonogenic Survival Assay
HCT 116 (1–3 3 105) or derivative mutants were seeded in 100 mm culture
plate and allowed to recover overnight. Cells were exposed to various doses
of DNA damage agents for 1 hr, washed, trypsinized, and reseeded with
appropriate densities in triplicate 100 mm plates. Colonies were fixed with
glutaraldehyde 6.0% (v/v) and visualized with 0.5% crystal violet (w/v). Clono-
genic survival of DT40 and derivative mutants against cisplatin was performed
inmedium contain 1.4%methylcellulosewith continuous exposed to indicated
concentrations of cisplatin (Nippon Kayaku).
Chromatin Fractionation and Chromatin IP
To obtain chromatin-bound protein fractions, cells were lysed and centrifuged
to collect insoluble pellet. The insoluble chromatin pellet was treatedwith 0.2 N
HCl and centrifuged to collect the supernatant. The eChIP assay was carried
out as previously described (Shen et al., 2009). Cisplatin-adducted plasmid
substrate was prepared by incubating with 15 mM cisplatin for 3 hr at 37C
in the dark, which produces on average three ICLs per kb.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2014.04.029.
ACKNOWLEDGMENTS
This work was supported by NIH grants (CA127945 and CA97175-Project 3 to
L.L., CA157448 to J.C., and Cancer Center Support Grant CA016672 to the
University of Texas MD Anderson Cancer Center) and Grants-in-Aid from
the Ministry of Education, Science, Sports and Culture of Japan (JSPS
KAKENHI 21390094 and MEXT KAKENHI 23114010 to M.T.). Y.H. is sup-
ported by the Hubert L. and Olive Stringer endowed professorship to L.L.ell Reports 7, 1849–1857, June 26, 2014 ª2014 The Authors 1855
Received: August 13, 2013
Revised: March 4, 2014
Accepted: April 15, 2014
Published: June 5, 2014
REFERENCES
Ali, A.M., Pradhan, A., Singh, T.R., Du, C., Li, J., Wahengbam, K., Grassman,
E., Auerbach, A.D., Pang, Q., and Meetei, A.R. (2012). FAAP20: a novel ubiq-
uitin-binding FA nuclear core-complex protein required for functional integrity
of the FA-BRCA DNA repair pathway. Blood 119, 3285–3294.
Alpi, A.F., Pace, P.E., Babu, M.M., and Patel, K.J. (2008). Mechanistic insight
into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and
FANCI. Mol. Cell 32, 767–777.
Blom, E., van de Vrugt, H.J., de Vries, Y., de Winter, J.P., Arwert, F., and
Joenje, H. (2004). Multiple TPR motifs characterize the Fanconi anemia
FANCG protein. DNA Repair (Amst.) 3, 77–84.
Bogliolo, M., Schuster, B., Stoepker, C., Derkunt, B., Su, Y., Raams, A., Trujillo,
J.P., Minguillo´n, J., Ramı´rez, M.J., Pujol, R., et al. (2013). Mutations in ERCC4,
encoding the DNA-repair endonuclease XPF, cause Fanconi anemia. Am. J.
Hum. Genet. 92, 800–806.
D’Andrea, A.D. (2010). Susceptibility pathways in Fanconi’s anemia and breast
cancer. N. Engl. J. Med. 362, 1909–1919.
Deans, A.J., and West, S.C. (2009). FANCM connects the genome instability
disorders Bloom’s Syndrome and Fanconi Anemia. Mol. Cell 36, 943–953.
Garcia-Higuera, I., Kuang, Y., Na¨f, D., Wasik, J., and D’Andrea, A.D. (1999).
Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a
functional nuclear complex. Mol. Cell. Biol. 19, 4866–4873.
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M.S., Timmers, C.,
Hejna, J., Grompe, M., and D’Andrea, A.D. (2001). Interaction of the Fanconi
anemia proteins and BRCA1 in a common pathway. Mol. Cell 7, 249–262.
Gordon, S.M., Alon, N., and Buchwald, M. (2005). FANCC, FANCE, and
FANCD2 form a ternary complex essential to the integrity of the Fanconi
anemia DNA damage response pathway. J. Biol. Chem. 280, 36118–36125.
Hodson, C., Purkiss, A., Miles, J.A., and Walden, H. (2014). Structure of the
human FANCL RING-Ube2T complex reveals determinants of cognate
E3-E2 selection. Structure 22, 337–344.
Huang, M., Kim, J.M., Shiotani, B., Yang, K., Zou, L., and D’Andrea, A.D.
(2010). The FANCM/FAAP24 complex is required for the DNA interstrand
crosslink-induced checkpoint response. Mol. Cell 39, 259–268.
Knipscheer, P., Ra¨schle, M., Smogorzewska, A., Enoiu, M., Ho, T.V., Scha¨rer,
O.D., Elledge, S.J., and Walter, J.C. (2009). The Fanconi anemia pathway pro-
motes replication-dependent DNA interstrand cross-link repair. Science 326,
1698–1701.
Kratz, K., Scho¨pf, B., Kaden, S., Sendoel, A., Eberhard, R., Lademann, C.,
Cannavo´, E., Sartori, A.A., Hengartner, M.O., and Jiricny, J. (2010). Deficiency
of FANCD2-associated nuclease KIAA1018/FAN1 sensitizes cells to inter-
strand crosslinking agents. Cell 142, 77–88.
Kruyt, F.A., Abou-Zahr, F., Mok, H., and Youssoufian, H. (1999). Resistance to
mitomycin C requires direct interaction between the Fanconi anemia proteins
FANCA and FANCG in the nucleus through an arginine-rich domain. J. Biol.
Chem. 274, 34212–34218.
Langevin, F., Crossan, G.P., Rosado, I.V., Arends, M.J., and Patel, K.J. (2011).
Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice.
Nature 475, 53–58.
Leung, J.W., Wang, Y., Fong, K.W., Huen, M.S., Li, L., and Chen, J. (2012).
Fanconi anemia (FA) binding protein FAAP20 stabilizes FA complementation
group A (FANCA) and participates in interstrand cross-link repair. Proc. Natl.
Acad. Sci. USA 109, 4491–4496.
Le´veille´, F., Blom, E., Medhurst, A.L., Bier, P., Laghmani, H., Johnson, M.,
Rooimans, M.A., Sobeck, A., Waisfisz, Q., Arwert, F., et al. (2004). The Fanconi
anemia gene product FANCF is a flexible adaptor protein. J. Biol. Chem. 279,
39421–39430.1856 Cell Reports 7, 1849–1857, June 26, 2014 ª2014 The AuthorsLing, C., Ishiai, M., Ali, A.M., Medhurst, A.L., Neveling, K., Kalb, R., Yan, Z.,
Xue, Y., Oostra, A.B., Auerbach, A.D., et al. (2007). FAAP100 is essential for
activation of the Fanconi anemia-associated DNA damage response pathway.
EMBO J. 26, 2104–2114.
Liu, T., Ghosal, G., Yuan, J., Chen, J., and Huang, J. (2010). FAN1 acts with
FANCI-FANCD2 to promote DNA interstrand cross-link repair. Science 329,
693–696.
Longerich, S., San Filippo, J., Liu, D., and Sung, P. (2009). FANCI binds
branched DNA and is monoubiquitinated by UBE2T-FANCL. J. Biol. Chem.
284, 23182–23186.
MacKay, C., De´clais, A.-C., Lundin, C., Agostinho, A., Deans, A.J., MacArtney,
T.J., Hofmann, K., Gartner, A., West, S.C., Helleday, T., et al. (2010). Identifica-
tion of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by
monoubiquitinated FANCD2. Cell 142, 65–76.
Medhurst, A.L., Laghmani, H., Steltenpool, J., Ferrer, M., Fontaine, C., de
Groot, J., Rooimans, M.A., Scheper, R.J., Meetei, A.R., Wang, W., et al.
(2006). Evidence for subcomplexes in the Fanconi anemia pathway. Blood
108, 2072–2080.
Meetei, A.R., deWinter, J.P., Medhurst, A.L., Wallisch, M., Waisfisz, Q., van de
Vrugt, H.J., Oostra, A.B., Yan, Z., Ling, C., Bishop, C.E., et al. (2003). A novel
ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35, 165–170.
Metzger, M.B., Hristova, V.A., and Weissman, A.M. (2012). HECT and RING
finger families of E3 ubiquitin ligases at a glance. J. Cell Sci. 125, 531–537.
Neveling, K., Endt, D., Hoehn, H., and Schindler, D. (2009). Genotype-pheno-
type correlations in Fanconi anemia. Mutat. Res. 668, 73–91.
Park, E., Kim, H., Kim, J.M., Primack, B., Vidal-Cardenas, S., Xu, Y., Price,
B.D., Mills, A.A., and D’Andrea, A.D. (2013). FANCD2 activates transcription
of TAp63 and suppresses tumorigenesis. Mol. Cell 50, 908–918.
Pulliam-Leath, A.C., Ciccone, S.L., Nalepa, G., Li, X., Si, Y., Miravalle, L.,
Smith, D., Yuan, J., Li, J., Anur, P., et al. (2010). Genetic disruption of both
Fancc and Fancg in mice recapitulates the hematopoietic manifestations of
Fanconi anemia. Blood 116, 2915–2920.
Rajendra, E., Oestergaard, V.H., Langevin, F., Wang, M., Dornan, G.L., Patel,
K.J., and Passmore, L.A. (2014). The genetic and biochemical basis of
FANCD2 monoubiquitination. Mol. Cell 54, Published online June 5, 2014.
http://dx.doi.org/10.1016/j.molcel.2014.05.001.
Reuter, T., Herterich, S., Bernhard, O., Hoehn, H., and Gross, H.J. (2000).
Strong FANCA/FANCG but weak FANCA/FANCC interaction in the yeast
2-hybrid system. Blood 95, 719–720.
Rosado, I.V., Langevin, F., Crossan, G.P., Takata, M., and Patel, K.J. (2011).
Formaldehyde catabolism is essential in cells deficient for the Fanconi anemia
DNA-repair pathway. Nat. Struct. Mol. Biol. 18, 1432–1434.
Sato, K., Toda, K., Ishiai, M., Takata, M., and Kurumizaka, H. (2012). DNA
robustly stimulates FANCD2 monoubiquitylation in the complex with FANCI.
Nucleic Acids Res. 40, 4553–4561.
Shen, X., Do, H., Li, Y., Chung, W.H., Tomasz, M., de Winter, J.P., Xia, B.,
Elledge, S.J., Wang, W., and Li, L. (2009). Recruitment of fanconi anemia
and breast cancer proteins to DNA damage sites is differentially governed
by replication. Mol. Cell 35, 716–723.
Smogorzewska, A., Matsuoka, S., Vinciguerra, P., McDonald, E.R., 3rd, Hurov,
K.E., Luo, J., Ballif, B.A., Gygi, S.P., Hofmann, K., D’Andrea, A.D., and Elledge,
S.J. (2007). Identification of the FANCI protein, a monoubiquitinated FANCD2
paralog required for DNA repair. Cell 129, 289–301.
Smogorzewska, A., Desetty, R., Saito, T.T., Schlabach, M., Lach, F.P.,
Sowa, M.E., Clark, A.B., Kunkel, T.A., Harper, J.W., Colaia´covo, M.P., and
Elledge, S.J. (2010). A genetic screen identifies FAN1, a Fanconi anemia-
associated nuclease necessary for DNA interstrand crosslink repair. Mol.
Cell 39, 36–47.
Taniguchi, T., Garcia-Higuera, I., Andreassen, P.R., Gregory, R.C., Grompe,
M., and D’Andrea, A.D. (2002). S-phase-specific interaction of the Fanconi
anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100, 2414–2420.
Waisfisz, Q., de Winter, J.P., Kruyt, F.A., de Groot, J., van der Weel, L., Dijk-
mans, L.M., Zhi, Y., Arwert, F., Scheper, R.J., Youssoufian, H., et al. (1999).
A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and
FANCA. Proc. Natl. Acad. Sci. USA 96, 10320–10325.
Wang, Y., Han, X., Wu, F., Leung, J.W., Lowery, M.G., Do, H., Chen, J., Shi, C.,
Tian, C., Li, L., andGong,W. (2013a). Structure analysis of FAAP24 reveals sin-
gle-stranded DNA-binding activity and domain functions in DNA damage
response. Cell Res. 23, 1215–1228.
Wang, Y., Leung, J.W., Jiang, Y., Lowery, M.G., Do, H., Vasquez, K.M., Chen,
J., Wang, W., and Li, L. (2013b). FANCM and FAAP24 maintain genome stabil-
ity via cooperative as well as unique functions. Mol. Cell 49, 997–1009.
Yamamoto, K., Ishiai, M., Matsushita, N., Arakawa, H., Lamerdin, J.E., Buer-
stedde, J.-M., Tanimoto, M., Harada, M., Thompson, L.H., and Takata, M.
(2003). Fanconi anemia FANCG protein in mitigating radiation- and enzyme-Cinduced DNA double-strand breaks by homologous recombination in verte-
brate cells. Mol. Cell. Biol. 23, 5421–5430.
Yan, Z., Guo, R., Paramasivam, M., Shen, W., Ling, C., Fox, D., 3rd, Wang, Y.,
Oostra, A.B., Kuehl, J., Lee, D.Y., et al. (2012). A ubiquitin-binding protein,
FAAP20, links RNF8-mediated ubiquitination to the Fanconi anemia DNA
repair network. Mol. Cell 47, 61–75.
Yuan, F., Qian, L., Zhao, X., Liu, J.Y., Song, L., D’Urso, G., Jain, C., and Zhang,
Y. (2012). Fanconi anemia complementation group A (FANCA) protein has
intrinsic affinity for nucleic acids with preference for single-stranded forms.
J. Biol. Chem. 287, 4800–4807.
Zimmerman, E.S., Schulman, B.A., and Zheng, N. (2010). Structural as-
sembly of cullin-RING ubiquitin ligase complexes. Curr. Opin. Struct. Biol.
20, 714–721.ell Reports 7, 1849–1857, June 26, 2014 ª2014 The Authors 1857
